Morning Breakouts

Latest KFF Health News Stories

FDA Nominee Played Role In Pushing More Fentanyl Into Circulation, Critics Claim

Morning Briefing

Scott Gottlieb’s part in getting Cephalon, a company that makes lollipops for cancer patients in extreme pain, more opioids lends itself to established concerns that the Trump administration’s pick to head the Food and Drug Administration is too closely tied to the drug industry. In other news on the opioid epidemic, special schools are helping teens stay sober and the use of painkillers in the middle-aged and elderly is skyrocketing.

Sanofi Claims Mylan Artificially Bumped Up EpiPen Prices, Then Undercut Competition With Rebates

Morning Briefing

The drugmaker filed a lawsuit against the troubled EpiPen-maker on Monday. In other pharmaceutical news, The Daily Beast investigates the involvement of Rep. Chris Collins, R-N.Y., with an Australian biotech company, a panel of U.S. scientists is questioning the methodology of an Ebola drug trial, Biogen releases the promising results of a drug to help children with a neuromuscular disease, and one California lawmaker has a plan for lowering drug prices.